(Translated by https://www.hiragana.jp/)
Avecia - Wikipedia Jump to content

Avecia

Add links
From Wikipedia, the free encyclopedia

This is the current revision of this page, as edited by Indignant Flamingo (talk | contribs) at 09:16, 3 June 2024 (clear out some promo/unsourced, replace cn tag with citation, fix other ref date). The present address (URL) is a permanent link to this version.

(diff) ← Previous revision | Latest revision (diff) | Newer revision → (diff)

Avecia, a part of Nitto Denko Inc., is a private biotechnology company focused on oligonucleotide production.[1] Avecia has two facilities, one near Boston, MA, and the second in Cincinnati, OH.[1] In 2016 Avecia acquired the assets of Irvine Pharmaceutical Services and Avrio Biopharmaceuticals.[2]

References[edit]

  1. ^ a b Kansteiner, Fraiser (March 31, 2021). "Nitto Denko lays out $226M to boost oligonucleotide production in a bustling RNA market". Fierce Pharma. Retrieved June 3, 2024.
  2. ^ "Nitto Denko Avecia Inc acquires businesses of Irvine Pharmaceutical Services, Avrio Biopharmaceuticals". Reuters. October 11, 2016. Retrieved June 3, 2024.

External links[edit]

Retrieved from "https://en.wikipedia.org/w/index.php?title=Avecia&oldid=1227040450"